CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
about
CRISPR-Mediated Epigenome EditingModeling Fragile X Syndrome Using Human Pluripotent Stem CellsEpigenetic Editing: On the Verge of Reprogramming Gene Expression at WillStabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.DNA Methylation Dynamics and Cocaine in the Brain: Progress and Prospects.Genetic and epigenetic control of gene expression by CRISPR-Cas systems.CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.Large-scale DNA methylation expression analysis across 12 solid cancers reveals hypermethylation in the calcium-signaling pathway.CRISPR Editing Technology in Biological and Biomedical Investigation.Editing the genome of hiPSC with CRISPR/Cas9: disease models.Editing DNA Methylation in the Mammalian Genome.Efficient Remyelination Requires DNA Methylation.Modern Genome Editing Technologies in Huntington's Disease Research.DNA methylation: an epigenetic mark of cellular memory.Site-specific recruitment of epigenetic factors with a modular CRISPR/Cas system.DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.Epigenetic Editing of Ascl1 Gene in Neural Stem Cells by Optogenetics.dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression.CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine.A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation.Am I ready for CRISPR? A user's guide to genetic screens.TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells.From Reductionism to Holism: Toward a More Complete View of Development Through Genome Engineering.Cancer induction and suppression with transcriptional control and epigenome editing technologies.A CRISPR reimagining: New twists and turns of CRISPR beyond the genome-engineering revolution.DNA-Methylation: Master or Slave of Neural Fate Decisions?Harnessing natural DNA modifying activities for editing of the genome and epigenome.TET-mediated epimutagenesis of the Arabidopsis thaliana methylome.Targeted DNA demethylation of the Arabidopsis genome using the human TET1 catalytic domain.DNA methylation in oligodendroglial cells during developmental myelination and in disease.Entering the post-epigenomic age: back to epigenetics.Epigenomics: Technologies and Applications.The CRISPR tool kit for genome editing and beyond.Blossom of CRISPR technologies and applications in disease treatmentHigh-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosisComprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profilingClass 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing
P2860
Q28075872-BCACF44E-E02B-41AB-9547-F5C88772A364Q28080022-55D7C932-8F7C-42DB-BCBE-FA5D883B87CDQ28080188-F5A06D0A-D538-4AF7-B8C7-B7C56E0C8D99Q30356570-AC14091D-5D34-4DC7-9625-AF4EC7AE7BC9Q33737457-B75A67A3-8089-485A-BCE7-131D873EFF2CQ33777855-400CE7FB-9F58-46CF-8E6E-9209B13EC5F9Q36331722-F73CBAEB-615F-4BD9-B7C1-59B0646AE6CAQ37707003-48DB8301-4038-41A1-8B27-31796AED1E1BQ38688945-FC56DEEC-E341-4A41-BA15-9C3B9393D5E0Q38711908-B5C440E6-C926-4B32-93D5-73A2DFDE3AC1Q38744151-06CE9F08-23FC-4A0E-B26D-55CAB46B06A7Q38815585-E9F32375-01FD-4B4F-89D5-F4D19ABEA036Q39106522-E8433E71-AAD0-45BF-BF9B-16785A843FBEQ39268179-BFECAB23-8F5C-4582-9609-D944BDEEF482Q40950027-55AB40AF-4B3F-4E16-B9F3-FAB3BB7C019EQ41706069-AEA9D1B7-5DE0-4803-A4F5-217726ABCEE5Q42322827-533D0211-D1FC-45F9-9143-973ED4D61333Q42367973-2954B29E-0476-48AB-A3C8-0E86079D1293Q46190066-7F9CC2CA-C2D2-41E7-A005-CC0688A9B473Q47264910-ADEEAD2F-B574-4640-8C78-383247E57F42Q47281660-FB8A8F14-80A8-4971-B180-4104C805AA77Q47331811-D9058AE3-4DED-42CB-98D6-8D985EC495CAQ47356373-A55F35F0-8D54-4372-8620-EE74FACA3D38Q47585554-A46FEBFB-F889-46B2-9FA2-BDF558DD4E19Q47659785-1ADCCC2C-AAB3-42A8-B85D-0216214ABAA6Q49380518-9A817334-9294-43BB-8908-4330645C23B5Q49917892-2B61EF38-D436-4C31-A1DF-F0A7517512D8Q50421268-5CE43BA0-FA2A-4C8F-BE3E-B067B3EF2689Q50422620-AB3C27C6-BF7F-457F-AF9F-99D9C5473AD4Q50455671-094051C9-75C9-400E-BAA8-EF4EF1E8DC0FQ52431111-FDE5ACE8-7D5B-474F-A235-CF0A8AD6241CQ52560351-2BD87DC4-085D-41F8-95BF-144FFAF01C58Q55233775-4D8DE4BE-4A21-4971-A21C-696C046A0992Q58120494-A69B1296-E208-4864-A36C-868B253A0731Q58695373-AF147056-3BD1-44B9-ABBD-6FC0C95909ECQ58755636-25B3C7AA-5F58-442A-88C6-2C7DED9AEC2BQ59127565-342A2FC0-F36B-434F-A4BD-AEA0418ED8BD
P2860
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
@en
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
@nl
type
label
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
@en
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
@nl
prefLabel
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
@en
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
@nl
P2093
P2860
P356
P1433
P1476
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter
@en
P2093
Barbara Stefanska
Samrat Roy Choudhury
P2860
P304
46545-46556
P356
10.18632/ONCOTARGET.10234
P407
P577
2016-07-01T00:00:00Z